Literature DB >> 21616141

Ironing out neurodegeneration: iron chelation for neuroprotection.

Joshua L Dunaief1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21616141      PMCID： PMC4380125          DOI： 10.1016/j.freeradbiomed.2011.05.009

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN： 0891-5849            Impact factor:   7.376


× No keyword cloud information.
  16 in total

1.  Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane.

Authors:  Paul Hahn; Ann H Milam; Joshua L Dunaief
Journal:  Arch Ophthalmol       Date:  2003-08

2.  Desferrioxamine ameliorates retinal photic injury in albino rats.

Authors:  Z L Li; S Lam; M O Tso
Journal:  Curr Eye Res       Date:  1991-02       Impact factor: 2.424

3.  Nigropallidal iron accumulation in pantothenate kinase-associated neurodegeneration demonstrated by susceptibility-weighted imaging.

Authors:  Jae-Hyeok Lee; Dae-Seong Kim; Seung-Kug Baik; Sang-Ook Nam
Journal:  J Neurol       Date:  2009-12-05       Impact factor: 4.849

4.  Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.

Authors:  Deepinder Kaur; Ferda Yantiri; Subramanian Rajagopalan; Jyothi Kumar; Jun Qin Mo; Rapee Boonplueang; Veena Viswanath; Russell Jacobs; Lichuan Yang; M Flint Beal; Dino DiMonte; Irene Volitaskis; Lisa Ellerby; Robert A Cherny; Ashley I Bush; Julie K Andersen
Journal:  Neuron       Date:  2003-03-27       Impact factor: 17.173

5.  Iron on the brain.

Authors:  T A Rouault
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

6.  Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload.

Authors:  Joshua L Dunaief; Chimene Richa; Edward P Franks; Robert L Schultze; Tomas S Aleman; John F Schenck; Earl A Zimmerman; David G Brooks
Journal:  Ophthalmology       Date:  2005-06       Impact factor: 12.079

Review 7.  Metal chelation as a potential therapy for Alzheimer's disease.

Authors:  M P Cuajungco; K Y Fagét; X Huang; R E Tanzi; A I Bush
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

8.  Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease.

Authors:  Zhanyun Lv; Hong Jiang; Huamin Xu; Ning Song; Junxia Xie
Journal:  J Neural Transm (Vienna)       Date:  2010-06-17       Impact factor: 3.575

9.  Deferroxamine preconditioning promotes long-lasting retinal ischemic tolerance.

Authors:  Yanli Zhu; Lihong Zhang; Jeffrey M Gidday
Journal:  J Ocul Pharmacol Ther       Date:  2008-12       Impact factor: 2.671

10.  Overexpressed or intraperitoneally injected human transferrin prevents photoreceptor degeneration in rd10 mice.

Authors:  Emilie Picard; Laurent Jonet; Claire Sergeant; Marie-Hélène Vesvres; Francine Behar-Cohen; Yves Courtois; Jean-Claude Jeanny
Journal:  Mol Vis       Date:  2010-12-08       Impact factor: 2.367
View more
  4 in total

Review 1.  Ophthalmic manifestations of inherited neurodegenerative disorders.

Authors:  Hannah M Kersten; Richard H Roxburgh; Helen V Danesh-Meyer
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

2.  Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants.

Authors:  Simon Gutbier; Sotiris Kyriakou; Stefan Schildknecht; Anna-Katharina Ückert; Markus Brüll; Frank Lewis; David Dickens; Liam Pearson; Joanna L Elson; Sylvia Michel; Véronique Hubscher-Bruder; Jeremy Brandel; David Tetard; Marcel Leist; Ilse S Pienaar
Journal:  Arch Toxicol       Date:  2020-06-30       Impact factor: 5.153

3.  Deferoxamine, Cerebrovascular Hemodynamics, and Vascular Aging: Potential Role for Hypoxia-Inducible Transcription Factor-1-Regulated Pathways.

Authors:  Farzaneh A Sorond; Can Ozan Tan; Sarah LaRose; Andrew D Monk; Raina Fichorova; Stanthia Ryan; Lewis A Lipsitz
Journal:  Stroke       Date:  2015-07-30       Impact factor: 7.914

4.  Degeneration modulates retinal response to transient exogenous oxidative injury.

Authors:  Michal Lederman; Shira Hagbi-Levi; Michelle Grunin; Alexey Obolensky; Eduard Berenshtein; Eyal Banin; Mordechai Chevion; Itay Chowers
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.